SUMMIT THERAPEUTICS INC's ticker is and the CUSIP is 86627T958. A total of 3 filers reported holding SUMMIT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,110 | -60.9% | 53,000 | -47.5% | 0.00% | -100.0% |
| Q2 2023 | $253,259 | -26.0% | 100,900 | -48.4% | 0.00% | 0.0% |
| Q1 2023 | $342,125 | -55.8% | 195,500 | +7.2% | 0.00% | -50.0% |
| Q4 2022 | $774,775 | +25725.8% | 182,300 | +16472.7% | 0.00% | – |
| Q4 2021 | $3,000 | -66.7% | 1,100 | -38.9% | 0.00% | – |
| Q3 2021 | $9,000 | +50.0% | 1,800 | +125.0% | 0.00% | – |
| Q2 2021 | $6,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 53,000 | $99,110 | 0.00% |
| SIMPLEX TRADING, LLC | 13,500 | $25 | 0.00% |